Monroe AT - Search Results

1

Angiosarcoma after breast-conserving therapy.

Monroe AT, Feigenberg SJ, Mendenhall NP. Monroe AT, et al. Cancer. 2003 Apr 15;97(8):1832-40. doi: 10.1002/cncr.11277. Cancer. 2003. PMID: 12673708 Free article. Review.

2

Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation.

Monroe AT, Hinerman RW, Amdur RJ, Morris CG, Mendenhall WM. Monroe AT, et al. Head Neck. 2003 Jul;25(7):529-34. doi: 10.1002/hed.10247. Head Neck. 2003. PMID: 12808655

3

Preventing radiation retinopathy with hyperfractionation.

Monroe AT, Bhandare N, Morris CG, Mendenhall WM. Monroe AT, et al. Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):856-64. doi: 10.1016/j.ijrobp.2004.07.664. Int J Radiat Oncol Biol Phys. 2005. PMID: 15708266

4

Does altered fractionation influence the risk of radiation-induced optic neuropathy?

Bhandare N, Monroe AT, Morris CG, Bhatti MT, Mendenhall WM. Bhandare N, et al. Among authors: monroe at. Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):1070-7. doi: 10.1016/j.ijrobp.2004.12.009. Int J Radiat Oncol Biol Phys. 2005. PMID: 15990010

5

Factors associated with radiation-induced nausea and vomiting in head and neck cancer patients treated with intensity modulated radiation therapy.

Monroe AT, Reddy SC, Gibbs GL, White GA, Peddada AV. Monroe AT, et al. Radiother Oncol. 2008 May;87(2):188-94. doi: 10.1016/j.radonc.2007.12.030. Epub 2008 Jan 30. Radiother Oncol. 2008. PMID: 18237801

6

Accelerated fractionation head and neck intensity-modulated radiation therapy and concurrent chemotherapy in the community setting: safety and efficacy considerations.

Monroe AT, Young JA, Huff JD, Ernster JA, White GA, Peddada AV. Monroe AT, et al. Head Neck. 2009 Sep;31(9):1144-51. doi: 10.1002/hed.21078. Head Neck. 2009. PMID: 19340861

7

Tracheobronchial amyloidosis: a case report of successful treatment with external beam radiation therapy.

Monroe AT, Walia R, Zlotecki RA, Jantz MA. Monroe AT, et al. Chest. 2004 Feb;125(2):784-9. doi: 10.1378/chest.125.2.784. Chest. 2004. PMID: 14769766

8

High-dose-rate brachytherapy for large prostate volumes (> or =50cc)-Uncompromised dosimetric coverage and acceptable toxicity.

Monroe AT, Faricy PO, Jennings SB, Biggers RD, Gibbs GL, Peddada AV. Monroe AT, et al. Brachytherapy. 2008 Jan-Mar;7(1):7-11. doi: 10.1016/j.brachy.2007.10.005. Brachytherapy. 2008. PMID: 18299109

9

Clinical outcomes of image guided radiation therapy (IGRT) with gold fiducial vaginal cuff markers for high-risk endometrial cancer.

Monroe AT, Pikaart D, Peddada AV. Monroe AT, et al. Acta Oncol. 2013 Jun;52(5):1010-6. doi: 10.3109/0284186X.2012.721932. Epub 2012 Sep 24. Acta Oncol. 2013. PMID: 22998475

10

Postoperative proton therapy in the management of stage III thymoma.

Figura N, Hoppe BS, Flampouri S, Su Z, Osian O, Monroe A, Nichols RC. Figura N, et al. J Thorac Oncol. 2013 May;8(5):e38-40. doi: 10.1097/JTO.0b013e31827a8911. J Thorac Oncol. 2013. PMID: 23584300 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters